New clinical trial registered for Glucagon

Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who Are Either Obese or Overweight With Weight-Related Comorbidities (SURMOUNT-1) (NCT07481747) registered on ClinicalTrials.gov. Phase: phase 3. Status: recruiting.